Title |
Zinc finger arrays binding human papillomavirus types 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasia
|
---|---|
Published in |
Theoretical Biology and Medical Modelling, July 2012
|
DOI | 10.1186/1742-4682-9-30 |
Pubmed ID | |
Authors |
Misaki Wayengera |
Abstract |
Human papillomavirus (HPV) types 16 and 18 are the high-risk, sexually transmitted infectious causes of most cervical intraepithelial neoplasias (CIN) or cancers. While efficacious vaccines to reduce the sexual acquisition of these high-risk HPVs have recently been introduced, no virus-targeted therapies exist for those already exposed and infected. Considering the oncogenic role of the transforming (E6 and E7) genes of high-risk HPVs in the slow pathogenesis of cervical cancer, we hypothesize that timely disruption or abolition of HPV genome expression within pre-cancerous lesions identified at screening may reverse neoplasia. We aimed to derive model zinc finger nucleases (ZFNs) for mutagenesis of the genomes of two high-risk HPV (types 16 & 18). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Uganda | 4 | 67% |
Unknown | 2 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 67% |
Scientists | 1 | 17% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 28 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 11 | 39% |
Student > Master | 4 | 14% |
Student > Bachelor | 4 | 14% |
Researcher | 3 | 11% |
Student > Doctoral Student | 2 | 7% |
Other | 1 | 4% |
Unknown | 3 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 29% |
Agricultural and Biological Sciences | 5 | 18% |
Immunology and Microbiology | 3 | 11% |
Nursing and Health Professions | 2 | 7% |
Social Sciences | 2 | 7% |
Other | 5 | 18% |
Unknown | 3 | 11% |